Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
J. Neurochem. (2012)122, 995–1009. Up‐regulation of proinflammatory cytokines and chemokines in brain (“neuroinflammation”) accompanies neurological disease and neurotoxicity. Previously, we documented a striatal neuroinflammatory response to acute administration of a neurotoxic dose of methamphetamine (METH), i.e. one associated with evidence of dopaminergic terminal damage and activation of microglia and astroglia. When we used minocycline to suppress METH‐induced neuroinflammation, indices of dopaminergic neurotoxicity were not affected, but suppression of neuroinflammation was incomplete. Here, we administered the classic anti‐inflammatory glucocorticoid, corticosterone (CORT), in an attempt to completely suppress METH‐related neuroinflammation. METH alone caused large increases in striatal proinflammatory cytokine/chemokine mRNA and subsequent astrocytic hypertrophy, microglial activation, and dopaminergic nerve terminal damage. Pre‐treatment of mice with acute CORT failed to prevent neuroinflammatory responses to METH. Surprisingly, when mice were pre‐treated with chronic CORT in the drinking water, an enhanced striatal neuroinflammatory response to METH was observed, an effect that was accompanied by enhanced METH‐induced astrogliosis and dopaminergic neurotoxicity. Chronic CORT pre‐treatment also sensitized frontal cortex and hippocampus to mount a neuroinflammatory response to METH. Because the levels of chronic CORT used are associated with high physiological stress, our data suggest that chronic CORT therapy or sustained physiological stress may sensitize the neuroinflammatory and neurotoxicity responses to METH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 1×
“Neuroinflammation has been associated with a variety of neurological diseases (for a review see: Prinz et al. 2011) and with neurotoxicant-induced damage to the CNS (for reviews see: Block et al. 2007; Sriram and O’Callaghan 2007; Kraft and Harry 2011).”
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 1×
“Damage to the CNS results in activation of microglia and astrocytes at sites of injury (Kreutzberg 1996; Eng et al. 2000; Norenberg 2005; O’Callaghan and Sriram 2005; Sofroniew 2005, 2009; Streit 2005).”
Dhabhar, F. S. (2009) · Neuroimmunomodulation · doi:10.1159/000216188 · Cited by 903
New Insights into the Mechanism of Action of Amphetamines
Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731 · cited 1×
“…degeneration staining (Ellinwood and Escalante 1970; Seiden et al. 1976; Hotchkiss et al. 1979; Bowyer et al. 1994; Miller and O’Callaghan 1994; O’Callaghan and Miller 1994, 2005; Bowyer and Holson 1995; Ladenheim et al. 2000; Thomas et al. 2004b; Fleckenstein et al. 2007; Krasnova and Cadet 2009).”
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674 · cited 3×
“Neuroinflammation has been associated with a variety of neurological diseases (for a review see: Prinz et al. 2011) and with neurotoxicant-induced damage to the CNS (for reviews see: Block et al. 2007; Sriram and O’Callaghan 2007; Kraft and Harry 2011).”
Wohleb, E. S., Hanke, M. L., Corona, A. W., Powell, N. D., Stiner, L. M., Bailey, M. T., Nelson, R. J., Godbout, J. P., & Sheridan, J. F. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0450-11.2011 · Cited by 638
Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578
Watkins, L. R., Hutchinson, M. R., Rice, K. C., & Maier, S. F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.002 · Cited by 438 · cited 2×
“Redistribution of cellular mediators of inflammation (Dhabhar 2009)and alteration in components of the toll signaling pathway (Watkins et al. 2009; Munhoz et al. 2010) remain as potential candidates.”
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425 · cited 1×
“The mechanisms through which CORT acts chronically to exert a proinflammatory effect in the intact or injured CNS have been proposed (Sorrells et al. 2009), but largely remain to be identified and characterized (Sorrells and Sapolsky 2007; Sorrells et al. 2009).”
Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392
Frank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303
Munhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274 · cited 4×
“These distinctions between the effects of acute CORT on METH versus LPS-related neuroinflammation suggest that the former involves damage-related microglial activation resistant to anti-inflammatory therapy, whereas the latter involves an acute phase response amenable to the anti-inflammatory effects of CORT.”
InfluentialPrior Stressor Exposure Sensitizes LPS-Induced Cytokine Production
Johnson, J. D., O'Connor, K. A., Deak, T., Stark, M., Watkins, L. R., & Maier, S. F. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0638 · Cited by 270
Quan, N., Stern, E. L., Whiteside, M. B., & Herkenham, M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00193-3 · Cited by 251 · cited 1×
“Activation of microglia and the enhanced expression of proinflammatory mediators constitute components of an acute phase response to systemic inflammation (Quan et al. 1999), effects distinct from, and that do not require, underlying CNS damage.”
Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · cited 18×
“As we previously observed for pre-treatment with minocycline (Sriram et al. 2006), TNF-α also remained resistant to suppression following pre-treatment with acute CORT.”
InfluentialSelf-citationStressor-specific alterations in corticosterone and immune responses in mice
Bowers, S. L., Bilbo, S. D., Dhabhar, F. S., & Nelson, R. J. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.07.012 · Cited by 222
Stress increases vulnerability to inflammation in the rat prefrontal cortex
de Pablos, R. M., Villarán, R. F., Argüelles, S., Herrera, A. J., Venero, J. L., Ayala, A., Cano, J., & Machado, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-06.2006 · Cited by 215
Munhoz, C. D., Sorrells, S. F., Caso, J. R., Scavone, C., & Sapolsky, R. M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0303-09.2010 · Cited by 169
Ladenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131 · cited 1×
“…degeneration staining (Ellinwood and Escalante 1970; Seiden et al. 1976; Hotchkiss et al. 1979; Bowyer et al. 1994; Miller and O’Callaghan 1994; O’Callaghan and Miller 1994, 2005; Bowyer and Holson 1995; Ladenheim et al. 2000; Thomas et al. 2004b; Fleckenstein et al. 2007; Krasnova and Cadet 2009).”
O'Callaghan, J. P., Brinton, R. E., & McEwen, B. S. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb08230.x · Cited by 131
Self-citationFrank, M. G., Watkins, L. R., & Maier, S. F. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.01.005 · Cited by 116
Cited by
Neuroinflammation in the normal aging hippocampus
Barrientos, R. M., Kitt, M. M., Watkins, L. R., & Maier, S. F. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.007 · Cited by 315
Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger
Frank, M. G., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.004 · Cited by 160
Principles of inflammasome priming and inhibition: implications for psychiatric disorders
Herman, F. J., & Pasinetti, G. M. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.06.010 · Cited by 115
Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson’s disease
Cuevas, E., Burks, S., Raymick, J., Robinson, B., Gómez-Crisóstomo, N. P., Escudero-Lourdes, C., Lopez, A. G. G., Chigurupati, S., Hanig, J., Ferguson, S. A., et al. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1859729 · Cited by 57
Relevance of chronic stress and the two faces of microglia in Parkinson's disease
Herrera, A. J., Espinosa-Oliva, A. M., Carrillo-Jiménez, A., Oliva-Martín, M. J., García-Revilla, J., García-Quintanilla, A., de Pablos, R. M., & Venero, J. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00312 · Cited by 42
Metadata
- Authors
- Kelly, K. A., Miller, D. B., Bowyer, J. F., & O’Callaghan, J. P.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2012-08-03
- Volume
- 122
- Issue
- 5
- Pages
- 995-1009
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1909001249
- Cited by
- 81
- References
- 21
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.